A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Dose-Response and Safety of STA-2 in Patients With Chronic Stable Angina.

Trial Profile

A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Dose-Response and Safety of STA-2 in Patients With Chronic Stable Angina.

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Aug 2014

At a glance

  • Drugs Polyphenon E (Primary)
  • Indications Angina pectoris
  • Focus Therapeutic Use
  • Sponsors Sinphar Pharmaceutical
  • Most Recent Events

    • 26 Aug 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 10 Aug 2011 Additional lead trial investigators identified as reported by ClinicalTrials.gov.
    • 10 Aug 2011 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top